Skip to main content
. 2017 Nov 12;23:5389–5395. doi: 10.12659/MSM.903927

Table 2.

The incidence rate of RASSF1A methylation.

Group Time Methylation Unmethylation Proportion of methylation
Test group (n=108) Before chemotherapy 48 60 44.44%***
After chemotherapy 23 85 21.30%***,##
Control group (n=78) At the beginning of the study 4 74 5.13%

* Indicated a significant difference between test group and control group, * P<0.05, ** P<0.01, *** P<0.001. # Predicted significant differences, compared with before chemotherapy, # P<0.05, ## P<0.01, ### P<0.001.